Stock BLUE BLUEBIRD BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.9229 USD -4.91% Intraday chart for bluebird bio, Inc. -4.19% -33.12%
Mar. 27 Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating MT
Mar. 27 Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell diseaseVertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease December 11, 2023 at 05:47 am EST
Global markets live: Valneva, Volkswagen, Uber, Tesla, Apple...Global markets live: Valneva, Volkswagen, Uber, Tesla, Apple... September 19, 2022 at 11:43 am EDT
Let the countdown beginLet the countdown begin September 19, 2022 at 10:12 am EDT
MarketScreener's World Press Review : August 18, 2022MarketScreener's World Press Review : August 18, 2022 August 18, 2022 at 08:17 am EDT
Global markets live: General Motors, JP Morgan, Pfizer, Novavax, Ford...Global markets live: General Motors, JP Morgan, Pfizer, Novavax, Ford... December 13, 2021 at 11:16 am EST
Today on Wall Street: Busy week aheadToday on Wall Street: Busy week ahead December 13, 2021 at 09:43 am EST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLUE Stock
  4. News bluebird bio, Inc.
  5. MarketScreener Editorial Features